Lexaria Bioscience Corp. Common Stock (LEXX) is a publicly traded Healthcare sector company. As of October 9, 2026, LEXX trades at $3.30 with a market cap of $6.74M and a P/E ratio of 0.00. LEXX moved +13.44% today. Year to date, LEXX is -67.38%; over the trailing twelve months it is -76.55%. Its 52-week range spans $2.77 to $28.43. Rallies surfaces LEXX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Nasdaq halts trading in LEXX for volatility at 2:07 p.m.: Nasdaq paused trading in LEXX for volatility at 2:07 p.m.
| Metric | Value |
|---|---|
| Price | $3.30 |
| Market Cap | $6.74M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $28.43 |
| 52-Week Low | $2.77 |
| Volume | 197.44K |
| Avg Volume | 0 |
| Revenue (TTM) | $705.92K |
| Net Income | $-11.91M |
| Gross Margin | 99.61% |
LEXX analyst coverage data. Average price target: $0.00.